Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non–Small Cell Lung Cancer in the Community Oncology Setting
Author(s) -
Carolyn J. Presley,
Daiwei Tang,
Pamela R. Soulos,
Anne C. Chiang,
Janina A. Longtine,
Kerin B. Adelson,
Roy S. Herbst,
Weiwei Zhu,
Nathan C. Nussbaum,
Rachael Sorg,
Vineeta Agarwala,
Amy P. Abernethy,
Cary P. Gross
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.9824
Subject(s) - medicine , lung cancer , oncology , ros1 , retrospective cohort study , cohort , cancer , personalized medicine , bioinformatics , adenocarcinoma , biology
Broad-based genomic sequencing is being used more frequently for patients with advanced non-small cell lung cancer (NSCLC). However, little is known about the association between broad-based genomic sequencing and treatment selection or survival among patients with advanced NSCLC in a community oncology setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom